External Funding Opportunities
We invite you to peruse the following list of funding opportunities that may be of interest to injury prevention researchers. This information is abstracted for brevity; please refer to the sponsor’s website for complete information.
To add other opportunities to this list, please email us.
In addition, we often publicize funding opportunities via our mailing list. Please become a member to join our mailing list and receive updated information.
- Grants to Support New Investigators in Addressing Cross-Cutting Violence Prevention and Opioid Overdose Prevention
- Preventing Violence Against Women in Priority Communities through Expanded Services
- Research Grants for Preventing Violence and Violence Related Injury (R01)
- E-Learning Collaborative for Sexual Violence and Intimate Partner Violence Prevention
- RFA-DA-19-005 — Science-Based Quality Measurement and Management Development for Opioid Use Disorder Treatment (R61/R33 Clinical Trial Required)
- Public Policy Effects on Alcohol-, Marijuana-, and Other Substance-Related Behaviors and Outcomes (R01)
- Public Policy Effects on Alcohol-, Marijuana-, and Other Substance-Related Behaviors and Outcomes (R21)
- Public Policy Effects on Alcohol-, Marijuana-, and Other Substance-Related Behaviors and Outcomes (R03)
- Justice Programme – Supporting Initiatives in the Field of Drugs Policy
- Syringe Access Program Grants
- Small Business Innovation Research Program Contract
- Addressing the Challenges of the Opioid Epidemic in Minority Health and Health Disparities Research in the U.S. (R21 Clinical Trial Optional)
- Addressing the Challenges of the Opioid Epidemic in Minority Health and Health Disparities Research in the U.S. (R01 Clinical Trial Optional)
- Development of Medications to Prevent and Treat Opioid Use Disorders and Overdose (UG3/UH3) (Clinical Trial Optional)
- PCORI Funding Announcement (PFA): Psychosocial Interventions with Office-Based Opioid Treatment (OBOT) for Opioid Use Disorder
- Addressing Disparities Program
- Medication-Assisted Treatment (MAT) Delivery for Pregnant Women with Substance Use Disorders Involving Prescription Opioids and/or Heroin Funding Initiative